Medtronic
 
 

Contegra® Pulmonary Valved Conduit
 

Contegra® Pulmonary Valved Conduit

The Natural Tissue Conduit Offering the Essential Features of a Homograft with the Convenience of a Bioprosthesis

Conduit Image

The Medtronic Contegra® bioprosthesis consists of a heterologous bovine jugular vein with a tri-leaflet venous valve and a natural sinus slightly larger in diameter than its lumen.

The conduit has been preserved in buffered glutaraldehyde solution in a concentration low enough to preserve the flexibility of the leaflet material.

Indications:

The Contegra® conduit is indicated for implantation into patients under 18 years of age presenting with the following clinical conditions:

  • Correction or reconstruction of the Right Ventricular Outflow Tract (RVOT) in congenital heart malformations (e.g., pulmonary atresia, pulmonary stenosis, tetralogy of Fallot, etc.).
  • Pulmonary valve replacement during the Ross procedure
  • Replacement of a previously implanted but dysfunctional pulmonary homograft or a failed pulmonary prosthesis.

Contegra® is available only in international markets where Contegra is released and pricing is approved.

References
  • Breymann T, Boethig D, Goerg R, Wolf-Rudinger T. The Contegra bovine valved jugular vein conduit for pediatric RVOT reconstruction: 4 years experience with 108 patients. J Card Surg. 2004;19:425-431.
  • Breymann T, Thies WR, Boethig D, et al. Bovine valved xenografts for RVOT reconstruction: results after 71 implants. Eu J Cardiothorac Surg. 2002;21:703-710.
  • Corno A, Humi C, et al. Glutaraldehyde-fixed bovin jugular vein as a substitute for the pulmonary valve in the Ross operation. J Thorac Cardiovasc Surg. 2001;122:493.
  • Perron J, Moran AM, et al. Valved homograft conduit repair of the right heart in early infancy. Ann Thorac Surg. 1999;68:542-548
  • Brawn WJ. The use of glutaraldehyde-preserved ovine pulmonary valve, as a pulmonary valve substitute in infants. Semin Thorac Cardiovasc Surg. 1995;7:154.
  • Corno A, Marcelletti C, et al. Long-term results after extracardiac valved conduits implanted for complex congenital heart disease. J Card Surg. 1988;3:495.
  • Fiore AC, Brown JW, et al. Valved and nonvalved right ventricular-pulmonary arterial extracardiac conduits. An experimental comparison. J Thorac Cardiovasc Surg. 1983;86:490.